Literature DB >> 9176111

Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor V beta genes.

H Shirwan1, L Barwari, D V Cramer.   

Abstract

We have recently shown that T cells infiltrating cardiac allografts early in graft rejection use a limited T-cell receptor (TCR) V beta repertoire. In this study we tested whether this limited repertoire of V beta genes is important for graft rejection. A cell line, AL2-L3, was established from LEW lymphocytes infiltrating ACI heart allografts 2 days after transplantation. This cell line is composed of CD4+ T cells that primarily recognize the class II RTI.B major histocompatibility complex (MHC) molecule expressed by the donor graft. This cell line precipitated acute rejection of donor hearts with a median survival time (MST) of 10.5 days following adoptive transfer to sublethally irradiated LEW recipients. This rate of graft rejection was significantly (P < 0.0007) accelerated when compared with a MST of 60 days for allografts in irradiated control recipients. The AL2-L3-mediated acceleration of graft rejection was donor specific as WF third-party heart allografts were rejected with a delayed tempo (MST = 28.5 days). The V beta repertoire of this cell line was primarily restricted to the expression of V beta 4, 15 and 19 genes. The nucleotide sequence analysis of the beta-chain cDNAs from this cell line demonstrated that the restricted use of the V gene repertoire was not shared with the N, D and J regions. A wide variety of CDR3 loops and J beta genes were used in association with selected V beta genes. These data provide evidence for the role a restricted repertoire of V beta genes plays in cardiac allograft rejection in this model. The restricted usage of the V beta repertoire in an early T-cell response to allografts may provide the opportunity to therapeutically disrupt the rejection reaction by targeting selected T-cell populations for elimination at the time of organ transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176111      PMCID: PMC1456687          DOI: 10.1046/j.1365-2567.1997.00187.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

Review 1.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

2.  Autologous peptides constitutively occupy the antigen binding site on Ia.

Authors:  S Buus; A Sette; S M Colon; H M Grey
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

3.  Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.

Authors:  J Schneck; T Munitz; J E Coligan; W L Maloy; D H Margulies; A Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes.

Authors:  D C Borie; D V Cramer; H Shirwan; G D Wu; O Rodriguez; F A Chapman; L Makowka
Journal:  Transplantation       Date:  1995-12-27       Impact factor: 4.939

5.  T cell receptor beta-chain selection in human allograft rejection.

Authors:  M C Miceli; O J Finn
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

6.  Crystal structure of the V alpha domain of a T cell antigen receptor.

Authors:  B A Fields; B Ober; E L Malchiodi; M I Lebedeva; B C Braden; X Ysern; J K Kim; X Shao; E S Ward; R A Mariuzza
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

7.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

Authors:  J L Urban; V Kumar; D H Kono; C Gomez; S J Horvath; J Clayton; D G Ando; E E Sercarz; L Hood
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

8.  The specificity and orientation of a TCR to its peptide-MHC class II ligands.

Authors:  D B Sant'Angelo; G Waterbury; P Preston-Hurlburt; S T Yoon; R Medzhitov; S C Hong; C A Janeway
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

9.  The outline structure of the T-cell alpha beta receptor.

Authors:  C Chothia; D R Boswell; A M Lesk
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

10.  Molecular genetic analysis of 178 I-Abm12-reactive T cells.

Authors:  J Bill; J Yagüe; V B Appel; J White; G Horn; H A Erlich; E Palmer
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  3 in total

1.  Diagnosis and treatment of acute rejection in the first case of human living-related small bowel transplantation with a long-term survival in China.

Authors:  Wei-Liang Song; Wei-Zhong Wang; Guo-Sheng Wu; Meng-Bin Li; Ji-Peng Li; Gang Ji; Guang-Long Dond; Hong-Wei Zhang
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

2.  Mouse xenoantigens contribute to rat T-cell Vbeta repertoire generation in mixed xenogeneic bone marrow chimeras.

Authors:  Y Huang; S T Ildstad; M Neipp; H Shirwan
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

3.  Clonal CD8+ T Cell Persistence and Variable Gene Usage Bias in a Human Transplanted Hand.

Authors:  Joseph Y Kim; Arumugam Balamurugan; Kodi Azari; Christian Hofmann; Hwee L Ng; Elaine F Reed; Suzanne McDiarmid; Otto O Yang
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.